Quick Answer
PUMA BIOTECHNOLOGY, INC. reported Total Assets of $216.30 million for fiscal year 2025.
PUMA BIOTECHNOLOGY, INC. Total Assets — Annual History
| Fiscal Year | Total Assets | YoY Change |
|---|---|---|
| 2025 | $216.30M | +1.4% |
| 2024 | $213.33M | -7.5% |
| 2023 | $230.53M | +3.8% |
| 2022 | $222.06M | -2.0% |
| 2021 | $226.59M | -7.2% |
| 2020 | $244.22M | +4.0% |
| 2019 | $234.91M | -9.3% |
| 2018 | $259.12M | +56.5% |
| 2017 | $165.53M | -34.5% |
| 2016 | $252.79M | +5.4% |
| 2015 | $239.84M | +47.4% |
| 2014 | $162.76M | +55.9% |
| 2013 | $104.37M | -31.2% |
| 2012 | $151.70M | +173.8% |
| 2011 | $55.40M | — |
Quarterly Total Assets
| Quarter Ending | Total Assets | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $202.86M | -8.1% | +4.1% |
| June 30, 2025 | $194.92M | -4.9% | -0.6% |
| March 31, 2025 | $196.18M | -8.4% | -8.0% |
| December 31, 2024 | $213.33M | -7.5% | -3.3% |
| September 30, 2024 | $220.72M | +8.4% | +7.7% |
| June 30, 2024 | $205.00M | +2.2% | -4.3% |
| March 31, 2024 | $214.15M | +9.1% | -7.1% |
| December 31, 2023 | $230.53M | +3.8% | +13.2% |
- PUMA BIOTECHNOLOGY, INC. showed an increase of +1.4% in Total Assets compared to the prior fiscal year.
- Over the 2011–2025 period, PUMA BIOTECHNOLOGY, INC.’s total assets has grown by 290.5% (from $55.40 million to $216.30 million).
- The most recent figure is from PUMA BIOTECHNOLOGY, INC.’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 26, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: